UNCOMMON EGFR MUTATIONS

Clinical trials for UNCOMMON EGFR MUTATIONS explained in plain language.

Never miss a new study

Get alerted when new UNCOMMON EGFR MUTATIONS trials appear

Sign up with your email to follow new studies for UNCOMMON EGFR MUTATIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope to stop lung Cancer's return after surgery

Disease control Recruiting now

This study is testing whether adding a new drug called zipalertinib to standard chemotherapy after lung cancer surgery works better than chemotherapy alone. It's for people with early-stage lung cancer who have specific, less common genetic changes in their tumor. The goal is to …

Matched conditions: UNCOMMON EGFR MUTATIONS

Phase: PHASE3 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

UNCOMMON EGFR MUTATIONS

Get alerted when new UNCOMMON EGFR MUTATIONS trials appear

New hope to stop lung Cancer's return after surgery